PT-141 (Bremelanotide) is a synthetic research peptide derived from melanocortin pathway analogs. This 10mg lyophilized powder is offered for qualified laboratory research and testing applications only. Commonly studied for its receptor-specific activity in scientific environments, PT-141 is not approved for medical use and is not intended for diagnostic or therapeutic procedures.

Each vial contains high-purity PT-141, suitable for in vitro experimentation under controlled research conditions.

Specifications

Compound: PT-141 (Bremelanotide)
Form: Lyophilized powder
Concentration: 10mg per vial
Purity: ≥98% (verified by HPLC)
Storage Conditions: Store at 2–8°C prior to reconstitution
Solubility: Suitable for reconstitution in sterile laboratory-grade diluents
Packaging: Sealed sterile glass vial

Research Use Statement

PT-141 is supplied strictly for research purposes. Any unauthorized handling, including use on humans or animals, is prohibited. The product is manufactured in accordance with research reagent standards and is intended for laboratory professionals familiar with peptide handling protocols.